Sulfanilamide has proved bacteriostatic against types I, II, III and XIV pneumococci in vitro and in laboratory animals, according to various authors.1 While the drug probably has been used widely for human pneumococcic pneumonia, the reports to date are meager. Heintzelman, Hadley and Mellon2 used it in nine cases of type III pneumonia and obtained seven recoveries, whereas among ten controls there were only two recoveries. Millett3 reported one case of type III pneumonia in which a crisis occurred after the use of sulfanilamide. Louis4 added six cases of pneumococcic pneumonia in which recovery occurred with sulfanilamide therapy.
The following report is based on 115 patients treated with sulfanilamide.5 compared with forty patients receiving serum and ninety-four controls receiving identical symptomatic and supportive measures but no specific therapy. While this series is too small to be statistically significant, it is reported in the hope that
PRICE AE, MYERS GB. TREATMENT OF PNEUMOCOCCIC PNEUMONIA WITH SULFANILAMIDE. JAMA. 1939;112(11):1021–1027. doi:10.1001/jama.1939.02800110001001
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: